CONVINCE
CONVINCE: COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke. A Multicentre, prospective randomized open label clinical trial
Purpose: The primary aim is to compare low-dose colchicine (0.5mg/day) plus usual care, to usual care alone, to prevent non-fatal recurrent ischaemic stroke and coronary events and vascular death after non-severe, noncardioembolic TIA/stroke.
Sponsor: University College Dublin, Ireland
ClinicalTrials.gov Identifier: NCT02898610
Local Principal Investigator: Dr. Albert Jin